Minimum Eligibility:

1. Applications must be submitted by entities registered and incorporated in India.
2. The proposal should be relevant and aligned to at least one of the problem statements given above.
3. The innovation should have completed the proof-of-concept stage and pre-clinical validation stage.
4. Applicant must submit validation data for justifying support for the next stage.
5. Transparency in furnishing relevant data in support of the proposed innovation should be agreeable by the applicant.
6. The innovation should be TRL- 5 and above (See FAQ for an explanation on TRL)

• Promising proposals at TRL 5, 6 & 7 will be supported for product development, clinical validation, regulatory approvals, and multi-centric trials
• Promising innovations at TRL 8 & 9 will be supported for evidence demonstration, community validation and acceleration.

7. The innovation should be superior to the currently available solutions or approaches in terms of sensitivity, specificity, accuracy, safety, turnaround time, usability in peripheral settings, unit pricing.
8. The innovation should have the potential for scale-up across diverse settings.
9. It is desirable if the innovation is amenable to being multi-disease applicable.

The following falls outside the scope of the Quest and will not be supported by IHF and KIIT-TBI:

1. Basic science research
2. Epidemiological studies/surveys/disease burden analysis
3. Proposals focused on pure service delivery
4. Innovations in the ideation/ proof-of-concept stage/ formative studies
5. Applications that propose incremental solutions without a clear innovative element
6. Non-alignment with national goals of the Government
7. Non-alignment with the Sustainability Development Goals (SDGs) related to healthcare